Skip to main content Skip to main navigation menu Skip to site footer

The comparison of platelet parameters in Platelet Rich Plasma (PRP) using Ethylenediaminetetraacetic Acid (EDTA) and Acid Citrate Dextrose (ACD) anticoagulants at Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia

  • Ullifannuri Rachmi ,
  • Tenri Esa ,
  • Uleng Bahrun ,
  • Darwati Muhadi ,


Background: Platelet Rich Plasma (PRP) is an autologous plasma with a platelet concentration above normal values. It contains high levels of growth factor, which plays an important role in tissue repair. The quality of PRP products is influenced by the platelet count, anticoagulants, speed, and centrifugation duration. This study aimed to determine the effectiveness of Ethylenediaminetetraacetic Acid (EDTA) and Acid Citrate Dextrose (ACD) in PRP preparation by measuring the platelet count (PLT) and platelet index (MPV and PDW).

Methods: Experimental laboratory study involved 25 volunteers performed at Hasanuddin University Hospital from September-October 2020. The values of PLT, MPV, PDW were measured using Sysmex XS-800i®. The parameters comparison between EDTA and ACD groups was analyzed using an independent T-test. A comparison of pre and post centrifugation was using paired T-test (significant if p<0.05). Data were analyzed using SPSS version 22 for Windows.

Results: The mean PLT in the EDTA sample was significantly lower than ACD (539.10x103/µL vs. 769.8x103/µL; p<0.05). Mean MPV and PDW in EDTA were significantly higher than ACD (10.7fL vs 8.9fL and 12.7fL vs 9,8fL; p<0,001). However, the mean MPV and PDW in the ACD sample did not change significantly (p>0.05).

Conclusion: PRP with ACD had a higher platelet count than EDTA, without significant platelet index changes.ACD is a more effective anticoagulant for the preparation of PRP than EDTA.



  1. Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet Physiology. Semin Thromb Hemost. 2016;42(3):191-204.
  2. Mulyantari NK, Prabawa IPY. Analysis of Soluble Cluster of Differentiation 40 Ligand (SD40L) levels between thrombocyte apheresis and thrombocyte whole blood products in Sanglah General Hospital blood bank. Bali Medical Journal. 2018;8(1):173-178.
  3. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24.
  4. Budak YU, Polat M, Huysal K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochem Med (Zagreb). 2016;26(2):178-193.
  5. Wu PI, Diaz R, Borg-Stein J. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-853.
  6. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014;7(4):189-197.
  7. Araki J, Jona M, Eto H, Aoi N, Kato H, Suga H, et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. 2012;18(3):176-185.
  8. Munawirah A, Esa T, Bahrun U. Analysis of Platelet Counts and Platelet-Derived Growth Factor-BB Levels in Platelet Rich Plasma Produced with EDTA as Anticoagulant in Three Different Centrifugation Methods. Indian Journal of Public Health Research & Development. 2020;11(6):1204-1209.
  9. do Amaral RJ, da Silva NP, Haddad NF, Lopes LS, Ferreira FD, Filho RB, et al. Platelet-Rich Plasma Obtained with Different Anticoagulants and Their Effect on Platelet Numbers and Mesenchymal Stromal Cells Behavior In Vitro. Stem Cells Int. 2016;2016:7414036.
  10. Taniguchi Y, Yoshioka T, Sugaya H, Gosho M, Aoto K, Kanamori A, et al. Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population. J Exp Orthop. 2019;6(1):1-8.
  11. Aizawa H, Kawabata H, Sato A, Masuki H, Watanabe T, Tsujino T, et al. A Comparative Study of The Effects of Anticoagulants on Pure Platelet-Rich Plasma Quality and Potency. Biomedicines. 2020;8(3):1-14.
  12. Tomer A, Schreiber AD, McMillan R, Cines DB, Burstein SA, Thiessen AR, et al. Menstrual cyclic thrombocytopenia. Br J Haematol. 1989;71(4):519-24.
  13. Singh S. Comparative (Quantitative and Qualitative) Analysis of Three Different Reagents for Preparation of Platelet-Rich Plasma for Hair Rejuvenation. J Cutan Aesthet Surg. 2018;11(3):127-131.
  14. Zhang N, Wang K, Li Z, Luo T. Comparative study of different anticoagulants and coagulants in the evaluation of clinical application of platelet-rich plasma (PRP) standardization. Cell Tissue Bank. 2019;20(1):61-75.

How to Cite

Rachmi, U., Esa, T., Bahrun, U., & Muhadi, D. (2021). The comparison of platelet parameters in Platelet Rich Plasma (PRP) using Ethylenediaminetetraacetic Acid (EDTA) and Acid Citrate Dextrose (ACD) anticoagulants at Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia. Indonesia Journal of Biomedical Science, 15(1), 87–91.